The New Drug/Biologics License Applications Review Process. What’s all the Fuss?

1 minute read

Published: January 29th, 2024

Presented by: LaRee Tracy, PhD, and Joshua Baker, PhD

Complete the form below to watch the webinar

Related articles

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls 

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls 

November 20th, 2025 1 minute read

Use of external data to augment clinical trials has been increasingly evaluated and is transforming drug development ...

SDTM Workflow Transformation: Faster, Easier and More Reliable

SDTM Workflow Transformation: Faster, Easier and More Reliable

November 14th, 2025 1 minute read

The demand for rapid, cost-effective, and standards-compliant SDTM delivery continues to increase across the biotech ...

Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines

Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines

October 30th, 2025 1 minute read

The early stages of clinical development are critical, decisions made here can determine the efficiency, cost, and ul...